Nimodipine, a calcium channel blocker, delays the spontaneous LH surge in women with regular menstrual cycles: a prospective pilot study

Reproductive Biology and Endocrinology

Research

Dan Nayot¹  Robert F Casper²  Shany Klachook³ 

[1] Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, 92 College Street, Toronto, Canada;Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, 92 College Street, Toronto, Canada;Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada;Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada;

关键词: Premature LH surge;    In-vitro fertilization (IVF);    GnRH agonist;    GnRH antagonist;    Calcium channel blocker;    Nimodipine;   

DOI  :  10.1186/1477-7827-11-7

 received in 2012-12-09, accepted in 2013-01-23,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundCurrently GnRH analogue injections are used to prevent premature LH surges in women undergoing assisted reproductive technology. This was a pilot study to determine the safety and effectiveness of nimodipine, an oral calcium channel blocker, to delay the mid-cycle spontaneous LH surge in women with regular menstrual cycles.MethodsEight women with regular menstrual cycles self-monitored three consecutive cycles for the day of an LH surge by daily urine assay. The first and third cycles were observatory. In the second cycle, subjects took nimodipine 60 mg by mouth three times daily for four days, starting two days prior to the expected LH surge day based on cycle one.ResultsThe LH surge day in cycle 2 (nimodipine) was significantly delayed in comparison to both observatory cycle 1 (15.5+/−3.4 vs 14.0+/−2.8 days; p = 0.033) and cycle 3 (15.1+/−3.5 vs 13.1+/−2.4 days; p = 0.044). There was no difference in the LH surge day between the two observatory cycles (13.4+/−2.4 vs 13.1+/−2.4 days; p = 0.457). Three patients experienced a mild headache.ConclusionsThere was a statistically significant delay in the spontaneous LH surge day in the treatment cycle in comparison to both observatory cycles. Nimopidine should be further investigated as an oral alternative to delay a spontaneous LH surge.

【 授权许可】

Unknown   
© Nayot et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.